Connection Between Epigenome, Selective Mutability, Evolution, and Human Disease
Li, Harris et al., PLoS Genetics
Researchers at the Baylor College of Medicine and elsewhere propose a "connection between the epigenome, selective mutability, evolution, and human disease" based on the findings of their study on associations of structural mutability with germline DNA methylation and with non-allelic homologous recombination mediated by low-copy repeats. "Combined evidence from four human sperm methylome maps, human genome evolution, structural polymorphisms in the human population, and previous genomic and disease studies consistently points to a strong association of germline hypomethylation and genomic instability," the Baylor-led team writes.
Informed Medical Decisions Acquires Inherited Health to Improve Disease Risk Data
May 04, 2011
"Inherited Health's comprehensive library and proprietary risk assessment tools will allow Informed Medical Decisions to offer our patients more options for personalizing their healthcare and sharing valuable information with their family," CEO David Nixon said in a statement.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register quickly here.
New to GenomeWeb? Register quickly here.
Related Stories
- In Wake of 'Flawed' GAO Report, Consumer Genomics Firms Call for Regulatory Plan for DTC Industry
July 28, 2010 / Pharmacogenomics Reporter - DTC Genomics Firms Say They Want to Comply with FDA Regs but Maintain Direct Access
March 16, 2011 / Pharmacogenomics Reporter - GAO Stands By Its 2010 Report on DTC Genomics Firms; Lead Investigator Assigned to New Position
March 16, 2011 / Pharmacogenomics Reporter - Advisory Committee Tells FDA Clinical Genetic Tests Should Only Be Provided Through Docs, Not DTC
March 9, 2011 / Pharmacogenomics Reporter - ASHG Studies Shed Light on Consumers' Understanding of Gene Scan Reports, Response to Results
November 10, 2010 / Pharmacogenomics Reporter